Lyell Competitors and Similar CompaniesClear all

Arvinas's competitors and similar companies include NovoCure.

	Arvinas Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases.	NovoCure NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors.
Type	Type Public	Type Public
Tags	Tags Healthcare Technology drug development oncology pharma platform therapy	Tags Healthcare biotech medical devices oncology platform therapy
Locations	Locations New Haven, US HQ	Locations Saint Helier, JE HQ München, DE Haifa, IL Tokyo, JP Root, CH Malvern, US New York, US see more
Employees	Employees 13329% increase	Employees 1,488
Valuation ($)	Valuation ($) 1.9 b	Valuation ($) 1.8 b
Financial
Revenue (est.)	Revenue (est.) $262.6m (FY, 2025)	Revenue (est.) $655.4m (FY, 2025)
Net income	Net income ($80.8m) (FY, 2025)	Net income ($136.2m) (FY, 2025)

For sources of this data, please see the company profile

Saint Helier, JE

Employees

1,488

NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors.

Financial